# Samyang signs partnership with Yxintent for dermal filler Lafullen in China

Samyang Holdings signed a partnership agreement with Hangzhou Yxintent for the export of Lafullen dermal filler to China. Yxintent will conduct clinical trials and obtain approval, then exclusively sell the product, with Samyang supplying about KRW 100 billion worth over five years.

- Type: Partnership
- Announced: 2023-06-07
- Where: China
- Value: $77.0M (100.0B KRW)
- Status: announced
- Products: Lafullen dermal filler (biodegradable polymer filler)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Samyang Corporation](https://endata.com/companies/29568.md)
- [Hangzhou Yxintent](https://endata.com/companies/70476.md) (partner)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/samyang-signs-partnership-agreement-with-yxintent-china-for-dermal-filler-lafullen-301841221.html), 2023-06-07: "Samyang Holdings signed a partnership agreement with Hangzhou Yxintent, a Chinese medical devices and aesthetics specialist company for the export of Lafullen."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.